Related Experiment Videos
Strategies for prolonged survival before heart transplantation in the neonatal intensive care unit
1Loma Linda University Medical Center, CA 92354.
Insights
Maintaining ductal patency is crucial for neonates awaiting heart transplants, especially those with hypoplastic left heart syndrome. Prostaglandin E1 infusions effectively manage ductal patency, ensuring hemodynamic stability in most infants.
Area of Science:
- Pediatric Cardiology
- Neonatal Intensive Care
- Congenital Heart Disease Management
Background:
- Neonatal heart transplantation is a complex procedure with significant preoperative management challenges.
- Maintaining ductal patency is critical for infants with congenital heart defects awaiting transplantation.
Purpose of the Study:
- To evaluate the management of ductal patency in neonates referred for heart transplantation.
- To address controversies in preoperative management, focusing on ductal closure and hemodynamic stability.
Main Methods:
- Retrospective analysis of over 200 fetuses and newborns referred for heart transplantation between 1989-1992.
- Monitoring of infants receiving prostaglandin E1 (PGE1) infusions for ductal patency maintenance.
- Evaluation of hemodynamic changes and interventions for managing pulmonary and systemic vascular resistance.
Main Results:
- Ductal closure was not a frequent threat to survival in most infants awaiting heart transplantation.
- Prostaglandin E1 (PGE1) infusions were effective in maintaining ductal patency in 83% of infants, primarily those with hypoplastic left-heart syndrome (HLHS).
- Variable shunting through the ductus caused rapid hemodynamic changes, necessitating pharmacologic or inhaled gas interventions.
Conclusions:
- While ductal closure is less of a threat than initially feared, careful hemodynamic management is essential for neonates awaiting heart transplantation.
- Prostaglandin E1 remains a key intervention, with innovative procedures like ductal stenting under evaluation for refractory cases.
- Optimizing pulmonary and systemic vascular resistance is crucial for improving outcomes in this vulnerable population.
Abstract:
From 1989 through 1992 we followed more than 200 fetuses and newborn infants referred for heart transplantation, of whom more than 140 were ultimately registered to receive a transplant. During this time, the interval before these infants underwent transplantation ranged from 1 day to 6 months. This experience left us with more questions than answers about the appropriate preoperative management of these patients. This article will focus on some of these areas of controversy. Our initial concern about the long-term management of these newborn infants was that ductal closure would be a major threat to their survival. However, our experience has proved otherwise. Although maintenance of ductal patency is a necessity for most neonatal transplantation candidates (83% have hypoplastic left-heart syndrome [HLHS] or one of its variants), the ductus has remained responsive to prostaglandin E1 (PGE1) infusion in most infants. For the rare infant whose ductus begins to close despite adequate PGE1 infusion, other innovative procedures (such as mechanical stenting of the ductus) have been devised and are currently under evaluation. Although ductal closure has not been a frequent occurrence in newborn infants awaiting heart transplantation, the variable shunting of blood through the ductus can cause significant and rapid changes in hemodynamics. This has prompted efforts to improve the balance between pulmonary and systemic vascular resistances by use of pharmacologic agents or by altering the mixture of inhaled gases. Attempts to decrease the PGE1 infusion and minimize exposure to other pulmonary vasodilators have been routine.(ABSTRACT TRUNCATED AT 250 WORDS)